The MarketWatch News Department was not involved in the creation of this content. SAN ANTONIO, Texas, Oct. 16, 2025 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ: FEMY), a leading biomedical innovator ...
The MarketWatch News Department was not involved in the creation of this content. Company Receives Three Additional Honors for Research into PGT Testing, Progesterone Surges During IVF, and Nutrition ...
First Fertility will bring its national network of fertility experts to the spotlight at the 2025 American Society for Reproductive Medicine (ASRM) Scientific Congress & Expo, held October 25–29, 2025 ...
“Our ASRM 2025 research will offer a comprehensive exploration of family building.” Topics from IVI RMA research that will be presented at the Congress include: Access and affordability of ...
BASKING RIDGE, N.J.--(BUSINESS WIRE)--IVI RMA North America, which comprises Reproductive Medicine Associates and Boston IVF, will present more than 50 infertility research studies at the American ...
SAN ANTONIO, Texas, Oct. 16, 2025 (GLOBE NEWSWIRE) -- Femasys Inc. (FEMY) (NASDAQ: FEMY), a leading biomedical innovator making fertility and non-surgical permanent birth control more accessible and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results